ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 245 filers reported holding ACADIA PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 0.36 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $184 | -15.6% | 8,884 | -23.6% | 0.00% | 0.0% |
Q1 2023 | $218 | -99.8% | 11,628 | +158.5% | 0.00% | – |
Q2 2021 | $110,000 | -44.7% | 4,499 | -41.7% | 0.00% | -100.0% |
Q1 2021 | $199,000 | +22.8% | 7,711 | +154.7% | 0.00% | 0.0% |
Q4 2020 | $162,000 | +362.9% | 3,028 | +257.1% | 0.00% | – |
Q3 2020 | $35,000 | -27.1% | 848 | -13.9% | 0.00% | – |
Q2 2020 | $48,000 | – | 985 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Baker Brothers Advisors | 27,228,338 | $611,821,000 | 5.19% |
First Washington CORP | 176,950 | $3,976,000 | 2.06% |
SECTORAL ASSET MANAGEMENT INC | 783,424 | $17,604,000 | 1.93% |
HARVEY CAPITAL MANAGEMENT INC | 219,042 | $4,921,000 | 1.84% |
Ghost Tree Capital, LLC | 400,000 | $8,988,000 | 1.82% |
Opus Point Partners Management, LLC | 36,733 | $825,000 | 1.62% |
Palo Alto Investors LP | 1,650,780 | $37,093,000 | 1.59% |
EMORY UNIVERSITY | 84,714 | $1,904,000 | 1.36% |
GARRISON BRADFORD & ASSOCIATES INC | 69,000 | $1,550,000 | 1.32% |
HealthCor Management, L.P. | 1,378,000 | $30,964,000 | 1.05% |